-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $11

Benzinga·04/29/2026 10:38:54
Listen to the news
BTIG analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and raises the price target from $10 to $11.